BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 29355335)

  • 1. The neuroscience of cognitive-motivational styles: Sign- and goal-trackers as animal models.
    Sarter M; Phillips KB
    Behav Neurosci; 2018 Feb; 132(1):1-12. PubMed ID: 29355335
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unresponsive Choline Transporter as a Trait Neuromarker and a Causal Mediator of Bottom-Up Attentional Biases.
    Koshy Cherian A; Kucinski A; Pitchers K; Yegla B; Parikh V; Kim Y; Valuskova P; Gurnani S; Lindsley CW; Blakely RD; Sarter M
    J Neurosci; 2017 Mar; 37(11):2947-2959. PubMed ID: 28193693
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 'Hot' vs. 'cold' behavioural-cognitive styles: motivational-dopaminergic vs. cognitive-cholinergic processing of a Pavlovian cocaine cue in sign- and goal-tracking rats.
    Pitchers KK; Kane LF; Kim Y; Robinson TE; Sarter M
    Eur J Neurosci; 2017 Dec; 46(11):2768-2781. PubMed ID: 29044780
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diverse Roads to Relapse: A Discriminative Cue Signaling Cocaine Availability Is More Effective in Renewing Cocaine Seeking in Goal Trackers Than Sign Trackers and Depends on Basal Forebrain Cholinergic Activity.
    Pitchers KK; Phillips KB; Jones JL; Robinson TE; Sarter M
    J Neurosci; 2017 Jul; 37(30):7198-7208. PubMed ID: 28659281
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Addiction vulnerability and the processing of significant cues: Sign-, but not goal-, tracker perceptual sensitivity relies on cue salience.
    Phillips KB; Sarter M
    Behav Neurosci; 2020 Apr; 134(2):133-143. PubMed ID: 31916796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuro-Immune Modulation of Cholinergic Signaling in an Addiction Vulnerability Trait.
    Carmon H; Haley EC; Parikh V; Tronson NC; Sarter M
    eNeuro; 2023 Mar; 10(3):. PubMed ID: 36810148
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cortico-striatal action control inherent of opponent cognitive-motivational styles.
    Avila C; Sarter M
    bioRxiv; 2024 Jun; ():. PubMed ID: 38559086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Basal Forebrain Chemogenetic Inhibition Converts the Attentional Control Mode of Goal-Trackers to That of Sign-Trackers.
    Kucinski A; Avila C; Sarter M
    eNeuro; 2022; 9(6):. PubMed ID: 36635246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The hot 'n' cold of cue-induced drug relapse.
    Pitchers KK; Sarter M; Robinson TE
    Learn Mem; 2018 Sep; 25(9):474-480. PubMed ID: 30115769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cholinergic control over attention in rats prone to attribute incentive salience to reward cues.
    Paolone G; Angelakos CC; Meyer PJ; Robinson TE; Sarter M
    J Neurosci; 2013 May; 33(19):8321-35. PubMed ID: 23658172
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Basal forebrain chemogenetic inhibition disrupts the superior complex movement control of goal-tracking rats.
    Kucinski A; Kim Y; Sarter M
    Behav Neurosci; 2019 Feb; 133(1):121-134. PubMed ID: 30688488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lesions of the ventral hippocampus attenuate the acquisition but not expression of sign-tracking behavior in rats.
    Fitzpatrick CJ; Creeden JF; Perrine SA; Morrow JD
    Hippocampus; 2016 Nov; 26(11):1424-1434. PubMed ID: 27438780
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The ability for cocaine and cocaine-associated cues to compete for attention.
    Pitchers KK; Wood TR; Skrzynski CJ; Robinson TE; Sarter M
    Behav Brain Res; 2017 Mar; 320():302-315. PubMed ID: 27890441
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Individual variation in the motivational properties of a nicotine cue: sign-trackers vs. goal-trackers.
    Yager LM; Robinson TE
    Psychopharmacology (Berl); 2015 Sep; 232(17):3149-60. PubMed ID: 25980485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Individual variation in the motivational and neurobiological effects of an opioid cue.
    Yager LM; Pitchers KK; Flagel SB; Robinson TE
    Neuropsychopharmacology; 2015 Mar; 40(5):1269-77. PubMed ID: 25425322
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Examining the role of dopamine D2 and D3 receptors in Pavlovian conditioned approach behaviors.
    Fraser KM; Haight JL; Gardner EL; Flagel SB
    Behav Brain Res; 2016 May; 305():87-99. PubMed ID: 26909847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sign-tracking predicts increased choice of cocaine over food in rats.
    Tunstall BJ; Kearns DN
    Behav Brain Res; 2015 Mar; 281():222-8. PubMed ID: 25541036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Addiction vulnerability trait impacts complex movement control: Evidence from sign-trackers.
    Kucinski A; Lustig C; Sarter M
    Behav Brain Res; 2018 Sep; 350():139-148. PubMed ID: 29705686
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lesions of the paraventricular nucleus of the thalamus differentially affect sign- and goal-tracking conditioned responses.
    Haight JL; Fraser KM; Akil H; Flagel SB
    Eur J Neurosci; 2015 Oct; 42(7):2478-88. PubMed ID: 26228683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The paraventricular thalamus is a critical mediator of top-down control of cue-motivated behavior in rats.
    Campus P; Covelo IR; Kim Y; Parsegian A; Kuhn BN; Lopez SA; Neumaier JF; Ferguson SM; Solberg Woods LC; Sarter M; Flagel SB
    Elife; 2019 Sep; 8():. PubMed ID: 31502538
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.